Quick Answer
Revium Rx. reported Stockholders Equity of $6.88 million for fiscal year 2025.
Revium Rx. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.88M | -65.1% |
| 2024 | $19.71M | — |
- Revium Rx. showed a decrease of -65.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2024–2025 period, Revium Rx.’s stockholders equity has declined by 65.1% (from $19.71 million to $6.88 million).
- The most recent figure is from Revium Rx.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: